These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Efficiency of isolation of revertible 6-thioguanine resistant clones is dependent on the concentration of thioguanine used for selection. Fox M. Carcinogenesis; 1981 Jun; 2(9):941-4. PubMed ID: 7296775 [Abstract] [Full Text] [Related]
33. Improvement in recovery of 6-thioguanine-resistant mutants by the use of inhibitors of metabolic cooperation in in vitro mutagenesis assay. Ochi T, Ohsawa M, Noda K, Umeda M. Jpn J Exp Med; 1982 Dec; 52(6):291-5. PubMed ID: 7169674 [No Abstract] [Full Text] [Related]
34. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L, Saranko CJ, Steen AM. Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [Abstract] [Full Text] [Related]
38. Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. Wei SJ, Chang RL, Bhachech N, Cui XX, Merkler KA, Wong CQ, Hennig E, Yagi H, Jerina DM, Conney AH. Cancer Res; 1993 Jul 15; 53(14):3294-301. PubMed ID: 8324741 [Abstract] [Full Text] [Related]
39. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene. Uematsu K, Yasuda J, Sekine T, Sugano K, Kudoh S, Sekiya T. Environ Mol Mutagen; 1997 Jul 15; 30(1):31-9. PubMed ID: 9258327 [Abstract] [Full Text] [Related]